Exclusive Box Office Report: Spider-Man crosses huge 55 cr nett in two days
Film will face stiff competition from Pushpa in south and thus its heading for 22.50 cr nett on day two. Film has collected 55 cr nett plus in two days.
Film will face stiff competition from Pushpa in south and thus its heading for 22.50 cr nett on day two. Film has collected 55 cr nett plus in two days.
The film has collected 7 cr nett more on opening day than Sooryavanshi. The film will collect 20-22 cr nett on day two and drop is normal considering a weekday release and competition from south release Pushpa.
Film was superb all over India but north circuits were still below the maximum capacity which is sign of concern.
As per the early estimates, it’s certain that film will cross 32 cr nett on day one (if not 34-35 cr nett) as it will also become the highest opener beating 26.50 cr nett of Sooryavanshi’s opening.
Both projects have their fair share of excitement among fans, but the MCU film is now the most popular pick among the general public. Shows that start as early as 6 a.m. are selling out.
Benedict Cumberbatch plays Doctor Strange, Jacob Batalon plays Ned Leeds, and Marisa Tomei plays Aunt May in the Tom Holland and Zendaya blockbuster.
Spiderman: No Way Home has met and beyond the expectations of the audience, and it can be stated that the film is a must-watch.
As per early trends, it’s certain that film will cross 28-30 cr nett on day one as it will also become highest opener beating 26 cr nett of Sooryavanshi.
Last month, Reliance Entertainment had pulled down the blockbuster Diwali film, Sooryavanshi, from their chain for a day after they missed on their payments.
As per early trends, the film will certainly cross 22-23 cr nett on day one and it can also become the highest opener beating 26 cr nett of Sooryavanshi.
The film has reintroduced audiences to the theatres in a big way, and the anticipation for it is the strongest for a feature film in India since Avengers: End Game.
First big blockbuster from Hollywood is on the card in post pandemic era.